In non-small cell lung cancer (NSCLC), SiRNA-mediated knockdown of PAR1 inhibited lung adenocarcinoma growth and invasion significantly, whereas PAR1 expression was increased by TGFβ [75,76]. Here, F2R is linked to non-small cell lung carcinoma.